Serodiagnosis of hepatitis C virus: Effect of new evaluation of cutoff values for enzyme-linked immunosorbent assay in Brazilian patients

American Journal of Clinical Pathology

Volumn 112, Issue 3, 1999, Pages 418-424

  Dos Santos, Vera A ^a   Azevedo, Raymundo S ^a   Camargo, Mario E ^a   Alves, Venâncio A F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cutoff; ELISA; Hepatitis C; Immunoblots; Serology

Indexed keywords

ARTICLE; BRAZIL; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; NORMAL VALUE; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0033490658     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/112.3.418     Document Type: Article

References (25)

1. Kuo G, Choo QL, Alter HJ, et al. An assay for circulating antibodies to major etiologic virus human non-A, non-B hepatitis. Science. 1989;244:362-364.
2. Choo QL, Weiner AJ, Overhy LR, et al. Isolation of a cDNA clone derived from a blood-home non-A, non-B viral hepatitis genome. Science. 1989;244:359-362.
3. McFarlane IG, Smith HM, Johnson PJ, et al. Hepatitis C virus antibodies in chronic active hepatitis: pathogenic factor or false-positive result? Lancet. 1990;335:754-757.
4. Lok ASF, Chien D, Choo QL, et al. Antibodies response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology. 1993;18:497-502.
5. Hsu HH, Gonzalez M, Foreng SKH, et al. Antibodies to hepatitis C virus in low-risk blood donors. Gastroenterology. 1991;101:1724-1727.
6. Lok ASF, Ma OCK, Chan JM, et al. Over-estimation of the prevalence of antibody to hepatitis C virus in retrospective studies in stored sera. Hepatology. 1991;14:546-552.
7. Aceti A, Taliani G, Bruni R, et al. Hepatitis C virus infection in chronic liver disease in Somalia. Am J Trop Med Hyg. 1993;48:581-584.
8. Ellis LA, Brown D, Conradie J, et al. Prevalence of hepatits C in South Africa: detection of anti-HCV in recent and stored serum. J Med Virol. 1990;32:249-251.
9. Wong DC, Diwan AR, Rosen L, et al. Non-specificity of anti-HCV test for seroepidemiological analysis. Lancet. 1990;336:750-751.
10. Vrienlink H, Zaaijer HL. Comparison of two anti-hepatitis C virus enzyme linked immunosorhent assays. Transfusion. 1995;35:601-604.
11. Vrienlink H, Zaaijer HL, Reesink HW, et al. Sensitivity and specificity of three third generation anti-hepatitis C virus ELISA. Vox Sang. 1995;69:14-17.
12. Riezu-Boj JI, Parker D, Civeira MP, et al. Detection of hepatitis C virus antibodies with new recombinant antigen: assessment in chronic liver disease. J Hepatol. 1992;15:309-313.
13. Chaveau P, Couroucé AM, Lemarec N, et al. Anti-hepatitis C virus by second generation test in hemodialysed patients. Kidney Int. 1993;43(suppl41):S149-S152.
14. Courocé AM, Marrec NLE, Girault A, et al. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing hemodialysis: comparison of second and third generation anti-HCV assays. Transfusion. 1994;34:790-795.
15. Uyttendaele S, Claes H, Mirtens W, et al. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang. 1994;66:122-129.
16. Van der Poel CL, Vrienlink H, Reesink HW, et al. Detection of anti-HCV seroconversion with new third generation HCV ELISA (ELISA3) and Immunoblot (RIBA3). Transfusion. 1993;33:S121.
17. Zaaijer HL, Cuypers HTM, Reesink HW, et al. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet. 1993;41:722-724.
18. Damen M, Cuyper HTM, Zaaijer HL, et al. International collaborative study on the second EUROPEP HCV-RNA reference panel. J Virol Methods. 1996;58:175-185.
19. Watanabe J, Matsumoto C, Fujimura K, et al. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viremia. Vox Sang. 1993;65:199-203.
20. Cohen JA. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37-46.
21. Maclure M, Willett W. Misinterpretation and misuse of the kappa statistic. J Epidemiol. 1987;126:161-169.
22. Galen RS, Gambino SR. Beyond normality: the predictive value and efficiency of medical diagnoses. New York, NY: Wiley; 1975.
23. Scott DA, Constantine NT, Callahan J, et al. The epidemiology of hepatitis C virus antibody in Yemen. Am J Trop Med Hyg. 1992;46:63-68.
24. Zehnder JL, Benson RL. Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V Leiden. Am J Clin Pathol. 1996;106:107-111.
25. Frider B, Sookoian S, Castano G, et al. Prevalence of hepatitis C in health care workers investigated by second generation enzyme-linked and line immunoassays. Acta Gastroenterol Latin Am. 1994;24:71-75.